Dementia with lewy bodies: A common condition in nursing homes?

Journal of the American Medical Directors Association

Volumn 14, Issue 10, 2013, Pages 713-714

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ALPHA SYNUCLEIN; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE;

ALZHEIMER DISEASE; AMNESIA; ATTENTION; AUTONOMIC NEUROPATHY; BEHAVIOR DISORDER; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DIZZINESS; DRUG SAFETY; DSM-IV; EDITORIAL; FALLING; HUMAN; HYPERSALIVATION; LEWY BODY; LOW DRUG DOSE; NEUROPATHY; NURSING HOME; NURSING HOME PATIENT; PARKINSON DISEASE; POLYPHARMACY; REM SLEEP DEPRIVATION; STANDING; SUBSTANTIA NIGRA; VISUAL HALLUCINATION;

ACCIDENTAL FALLS; APATHY; ATTENTION; AUTONOMIC NERVOUS SYSTEM DISEASES; DIZZINESS; DREAMS; HALLUCINATIONS; HUMANS; LEWY BODY DISEASE; NURSING HOMES; REM SLEEP BEHAVIOR DISORDER; SIALORRHEA; SYNCOPE;

EID: 84884584402     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.07.009     Document Type: Editorial

References (41)

1. Goedert M., Spillantini M.G., Del Tredici K., Braak H. 100 years of Lewy pathology. Nat Rev Neurol 2013, 9:13-24.
2. Kosaka K., Yoshimura M., Ikeda K., Budka H. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?. Clin Neuropathol 1984, 3:185-192.
3. Hansen L.A., Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997, 48:126-132.
4. Weisman D., McKeith I. Dementia with Lewy bodies. Semin Neurol 2007, 27:42-47.
5. Boyle PA, Wilson RS, Yu L, etal. Much of late life cognitive decline is not due to common neurodegenerative pathologies [published online ahead of print June 24, 2013]. Ann Neurol. http://dx.doi.org/10.1002/ana.23964.
6. Voyer P., Richard S., McCusker J., et al. Detection of delirium and its symptoms by nurses working in a long term care facility. JAm Med Dir Assoc 2012, 13:264-271.
7. Flaherty J.H., Rudolph J., Shay K., et al. Delirium is a serious and under-recognized problem: Why assessment of mental status should be the sixth vital sign. JAm Med Dir Assoc 2007, 8:273-275.
8. Bellelli G., Speciale S., Morghen S., et al. Are fluctuations in motor performance a diagnostic sign of delirium?. JAm Med Dir Assoc 2011, 12:578-583.
9. Saliba D., Jones M., Streim J., et al. Overview of significant changes in the Minimum Data Set for nursing homes version 3.0. JAm Med Dir Assoc 2012, 13:595-601.
10. Mollenhauer B., Förstl H., Deuschl G., et al. Lewy body and parkinsonian dementia: Common, but often misdiagnosed conditions. Dtsch Arztebl Int 2010, 107:684-691.
11. Cholerton B., Larson E.B., Baker L.D., et al. Neuropathologic correlates of cognition in a population-based sample. JAlzheimers Dis 2013, 36:699-709.
12. Cagnin A., Gnoato F., Jelcic N., et al. Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies. JNeurol Neurosurg Psychiatry 2013, 84:505-510.
13. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
14. Pao W.C., Boeve B.F., Ferman T.J., et al. Polysomnographic findings in dementia with Lewy bodies. Neurologist 2013, 19:1-6.
15. Rapp M.A., Mell T., Majic T., et al. Agitation in nursing home residents with dementia (VIDEANT Trial): Effects of a cluster-randomized, controlled, guideline implementation trial. JAm Med Dir Assoc 2013, 14:690-695.
16. Volicer L. Is your nursing home a battlefield?. JAm Med Dir Assoc 2012, 13:195-196.
17. Morley J.E. Dementia-related agitation. JAm Med Dir Assoc 2011, 12:611-612.e2.
18. Volicer L. Behaviors in advanced dementia. JAm Med Dir Assoc 2009, 10:146. author reply 146-147.
19. Volicer L. Toward better terminology of behavioral symptoms of dementia. JAm Med Dir Assoc 2012, 13:3-4.
20. Volicer L., Frijters D.H., van der Steen J.T. Apathy and weight loss in nursing home residents: Longitudinal study. JAm Med Dir Assoc 2013, 14:417-420.
21. Hölttä E.H., Laakkonen M.L., Laurila J.V., et al. Apathy: Prevalence, associated factors, and prognostic value among frail, older inpatients. JAm Med Dir Assoc 2012, 13:541-545.
22. Morley J.E. Syncope. J Am Med Dir Assoc 2013, 14:311-312.
23. Rapp K., Becker C., Cameron I.D., et al. Epidemiology of falls in residential aged care: Analysis of more than 70,000 falls from residents of Bavarian nursing homes. JAm Med Dir Assoc 2012, 13:187.e1-187.e6.
24. Messinger-Rapport B.J., Cruz-Oliver D.M., Thomas D.R., Morley J.E. Clinical update on nursing home medicine: 2012. JAm Med Dir Assoc 2012, 13:581-594.
25. Gama Z.A., Medina-Mirapeix F., Saturno P.J. Ensuring evidence-based practices for falls prevention in a nursing home setting. JAm Med Dir Assoc 2011, 12:398-402.
26. Taki J., Yoshita M., Yamada M., Tonami N. Significance of 1231-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: It can be a specific marker for Lewy body disease. Ann Nucl Med 2004, 18:453-461.
27. Touchon J., Bergman H., Bullock R., et al. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. Curr Med Res Opin 2006, 22:49-59.
28. Tolson D., Rolland Y., Andrieu S., et al. The International Association of Gerontology and Geriatrics/World Health Organization/Society Française Gérontologie et de Gériatrie Task Force. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. JAm Med Dir Assoc 2011, 12:184-189.
29. Morley J.E. Anticholinergic medications and cognition. JAm Med Dir Assoc 2011, 12:543-543.e1.
30. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: Thepolypharmacy outcomes project. JAm Med Dir Assoc 2012, 13:818.e11-818.e15.
31. Morley J.E. Polypharmacy in the nursing home. JAm Med Dir Assoc 2009, 10:289-291.
32. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. JAm Med Dir Assoc 2011, 12:326-330.
33. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. JAm Med Dir Assoc 2010, 11:475-484.
34. Morley J.E., Vellas B., Abellan van Kan G., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
35. Shimada H., Makizako H., Doi T., et al. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. JAm Med Dir Assoc 2013, 14:518-524.
36. Rougé Bugat M.E., Cestac P., Oustric S., et al. Detecting frailty in primary care: A major challenge for primary care physicians. JAm Med Dir Assoc 2012, 13:669-672.
37. Hoogendijk E.O., van Hout H.P. Investigating measurement properties of the Groningen Frailty Indicator: A more systematic approach is needed. JAm Med Dir Assoc 2012, 13:757.
38. Peters L.L., Boter H., Buskens E., Slaets J.P. Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people. JAm Med Dir Assoc 2012, 13:546-551.
39. Dent E., Visvanathan R., Piantadosi C., Chapman I. Use of the Mini Nutritional Assessment to detect frailty in hospitalized older people. JNutr Health Aging 2012, 16:764-767.
40. Subra J., Gillette-Guyonnet S., Cesari M., et al. The integration of frailty into clinical practice: Preliminary results from the Gérontopóle. JNutr Health Aging 2012, 16:714-720.
41. Morley J.E., Malmstrom T.K., Miller D.K. Asimple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. JNutr Health Aging 2012, 16:601-608.